Related Experiment Video

Updated: May 14, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

The role of miRNA-29 family in cancer

Yang Wang1, Xinwei Zhang, Hui Li

  • 1Department of Oncology, Tianjin Medical University, Tianjin, China. hutu120@sina.com

European Journal of Cell Biology
|January 30, 2013
PubMed

Insights

The miRNA-29 family, including miR-29a, miR-29b, and miR-29c, plays a key role in cancer development. This review explores their function in cancer cell changes and epigenetic and immune regulation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The miRNA-29 family (miR-29a, miR-29b, miR-29c) is frequently dysregulated in various cancers.
  • Aberrant expression of miR-29s is linked to tumorigenesis and cancer progression.
  • This family is extensively studied in cancer research.

Purpose of the Study:

  • To review the role of the miRNA-29 family in cancer pathophysiology.
  • To summarize the involvement of miR-29s in epigenetic regulation within cancer.
  • To outline the impact of miR-29s on immune regulation in cancer.

Main Methods:

  • Literature review of studies on miRNA-29 family in cancer.
  • Analysis of research on miR-29s' involvement in cancer cell pathophysiology.
  • Synthesis of data regarding epigenetic and immune regulatory functions of miR-29s.

Main Results:

  • The miRNA-29 family influences key pathophysiologic changes in cancer cells.
  • miR-29s are implicated in epigenetic modifications relevant to cancer.
  • The family plays a role in the immune response within the tumor microenvironment.

Conclusions:

  • The miRNA-29 family is a critical factor in cancer development and progression.
  • Understanding miR-29s' functions offers insights into novel cancer therapies.
  • Further research into miR-29s' epigenetic and immune roles is warranted.

More Related Videos

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...